From May 22nd to 25th, 2025, the 2025 DIA Drug Information Conference and Exhibition hosted by the Drug Information Association (DIA) was held in Shanghai. With the theme of “Bringing Together Global Wisdom to Lead Medical Innovation”, the conference brought together representatives from global drug regulatory agencies, scientific researchers, and industry elites to discuss international cooperation and innovative development in the biopharmaceutical field. The conference attracted thousands of industry experts from more than 30 countries and regions around the world, and nearly 100 top domestic and international clinical trial institutions as well as over 200 leading industry enterprises participated in exhibition and communication. Peking University Third Hospital (PKUTH) was invited to attend the conference and set up an exhibition booth.

　　The PKUTH booth

　　During the DIA Conference, Director Li Haiyan of the Drug Clinical Trial Institution of PKUTH led a 10 - person team to carry out reception work at the booth. The team received many important guests, including: Deputy Director Wang Hainan of the Drug Registration Department of the National Medical Products Administration (NMPA), Deputy Director Wang Xiangyu of the China International Exchange Center for Food and Drug (CINDA), Dr. Li Zili, director of DIA and the FDA Colleagues Association, Dr. Bandar Al Hammad, Executive Director of the Regulatory Affairs Department of the Saudi Food and Drug Authority (Saudi FDA), as well as colleagues from industry, academia, and the medical field.

　　Written by: Wu Zhaoxia

　　Edited by: LiuXin

　　Source: Peking University Third Hospital